Group One Trading
ERNA icon

Group One Trading’s Eterna Therapeutics ERNA Stock Holding History

Group One Trading’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1
Closed -$21K – 7985
2022
Q1 		$21K Sell
1
-1
-50% -$19K ﹤0.01% 6708
2021
Q4 		$48K Hold
2
– – ﹤0.01% 6369
2021
Q3 		$105K Sell
2
-1
-33% -$86.3K ﹤0.01% 5860
2021
Q2 		$434K Buy
+3
New +$432K ﹤0.01% 4370

Other funds holding ERNA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
SCA
Sippican Capital Advisors Boston, Massachusetts $164M AUM 35.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $3.28B AUM 23.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Group One Trading's ERNA Position: Q2 2025 in Review

Group One Trading held its Eterna Therapeutics (ERNA) position steady in Q2 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #8092.

Group One Trading first reported a position in ERNA in Q2 2021 and has held it in 1 quarter since. The position peaked at $290K in Q2 2021. 9 funds tracked by Wall St. Rank hold ERNA as of Q2 2025.

  • Group One Trading held 0 shares of Eterna Therapeutics worth $0 as of Q2 2025.
  • Group One Trading left its Eterna Therapeutics share count unchanged in Q2 2025.
  • Eterna Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2025, its #8092 holding.
  • Group One Trading first reported a position in Eterna Therapeutics in Q2 2021 and has held it in 1 quarter since.
  • Group One Trading's Eterna Therapeutics position peaked at $290K in Q2 2021.
  • 9 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.